Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study.

Saved in:
Bibliographic Details
Title: Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study.
Authors: Sheshadri A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Goizueta AA; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shannon VR; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., London D; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi-Kashani F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva MY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zarifa A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Albittar AA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhong LL; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Akhmedzhanov FO; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Arain MH; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alfayez M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alotaibi A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mendoza TR; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas., Godoy MCB; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shroff G; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kim ST; Department of Rheumatology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Faiz SA; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kontoyiannis DP; Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khawaja F; Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jennings K; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Source: Cancer [Cancer] 2022 Jul 15; Vol. 128 (14), pp. 2736-2745. Date of Electronic Publication: 2022 Apr 22.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first